Most new medicines are first tested elsewhere. And that could cost Europe future innovation
Europe is testing plenty of new medicines—but mostly at the later stages. The earliest, most experimental studies, where drugs are first tried in humans, remain surprisingly scarce. According to Dr…
EU Perspectives Podcast
23:18
EU budget showdown: MEP Nerudová on power struggles, cuts and new…
26:53
Inside Europe’s hidden epidemics: Mental health and the policy gap
45:12
Joint procurement saved vaccines. Can it solve medicine shortages, too?
38:56
European defence needs a trust boost
43:43
MEPs on how to save European farming
42:51
EU needs unity, clear regulation on immigration, insiders agree
53:30
For EU to survive, beefing up militaries is not enough
48:39
Changing priorities may force EU to work around budget constraints
33:12
Jens Gieseke, chief EPP negotiator: European Commission must propose new automotive rules swiftly
0:40
